The required experience of open pancreaticoduodenectomy before becoming a specialist in hepatobiliary and pancreatic surgeons: a multicenter, cohort study of 334 open pancreaticoduodenectomies
Tomokazu Fuji(Okayama University), T Fujiwara(Okayama University), Toshiharu Mitsuhashi(Okayama University Hospital), Daisuke Nobuoka(Fukuyama City Hospital), Kosei Takagi(Okayama Shoka University), Yuzo Umeda(Okayama University), Yoshikatsu Endo(Himeji Red Cross Hospital), Masayoshi Hioki(Fukuyama City Hospital), Kazuya Yasui(Okayama University), Ryuichi Yoshida(Okayama University)
Cited by 1
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178
Risk factors for major morbidity after liver resection for hepatocellular carcinoma
|British journal of surgery|2012|104
Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma
|World Journal of Surgery|2017|95
Risk factors for acute renal injury in living donor liver transplantation: evaluation of the RIFLE criteria
|Transplant International|2013|92